Bibliography
- Kober L, Torp-Pedersen C, McMurray JJ, Increased mortality after dronedarone therapy for severe heart failure. N Engl J Med 2008;358:2678-87
- Naccarelli GV, Wolbrette DL, Khan M, Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials. Am J Cardiol 2003;91:15D-26D
- Moller M, Torp-Pedersen CT, Kober L. Dofetilide in patients with congestive heart failure and left ventricular dysfunction: safety aspects and effect on atrial fibrillation. The Danish Investigators of Arrhythmia and Mortality on Dofetilide (DIAMOND) Study Group. Congest Heart Fail 2001;7:146-50
- Kober L, Bloch Thomsen PE, Moller M, Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial. Lancet 2000;356:2052-8
- Pedersen HS, Elming H, Seibaek M, Risk factors and predictors of Torsade de pointes ventricular tachycardia in patients with left ventricular systolic dysfunction receiving dofetilide. Am J Cardiol 2007;100:876-80
- Brendorp B, Elming H, Jun L, Qtc interval as a guide to select those patients with congestive heart failure and reduced left ventricular systolic function who will benefit from antiarrhythmic treatment with dofetilide. Circulation 2001;103:1422-7
- Roy D, Talajic M, Dorian P, Canadian Trial of Atrial Fibrillation Investigators. Amiodarone to prevent recurrence of atrial fibrillation. N Engl J Med 2000;342:913-20
- Wyse DG, Waldo AL, DiMarco JP, A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-33
- Van Gelder IC, Hagens VE, Bosker HA, A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002;347:1834-40
- Roy D, Talajic M, Nattel S, Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 2008;358:2667-77
- Corley SD, Epstein AE, DiMarco JP, Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation 2004;109:1509-13
- Gautier P, Guillemare E, Marion A, Electrophysiologic characterization of dronedarone in guinea pig ventricular cells. J Cardiovasc Pharmacol 2003;41:191-202
- Chatelain P, Meysmans L, Matteazzi JR, Interaction of the antiarrhythmic agents SR 33589 and amiodarone with the beta-adrenoceptor and adenylate cyclase in rat heart. Br J Pharmacol 1995;116:1949-56
- Zimetbaum PJ. Dronedarone for atrial fibrillation–an odyssey. N Engl J Med 2009;360:1811-3
- Touboul P, Brugada J, Capucci A, Dronedarone for prevention of atrial fibrillation: a dose-ranging study. Eur Heart J 2003;24:1481-7
- Singh BN, Connolly SJ, Crijns HJ, Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. N Engl J Med 2007;357:987-99
- Mazzini MJ, Monahan KM. Pharmacotherapy for atrial arrhythmias: present and future. Heart Rhythm 2008;5:S26-31
- Tschuppert Y, Buclin T, Rothuizen LE, Effect of dronedarone on renal function in healthy subjects. Br J Clin Pharmacol 2007;64:785-91
- Davy JM, Herold M, Hoglund C, Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study. Am Heart J 2008;156:527 e1-9
- Hohnloser SH, Crijns HJ, van Eickels M, Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med 2009;360:668-78
- Connolly SJ, Crijns HJ, Torp-Pedersen C, Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter. Circulation 2009;120:1174-80
- Barquet P. DIONYSOS Study Results Showed the Respsective Profiles of Dronedarone and Amiodarone. Press release. Available from: http://en.sanofi-aventis.com/binaries/20081223_dionysos_fe_en_en_tcm28-23624.pdf. [Accessed 17 November 2009]
- Piccini JP, Hasselblad V, Peterson ED, Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation. J Am Coll Cardiol 2009;54:1089-95
- Zimetbaum P, Ho KK, Olshansky B, Variation in the utilization of antiarrhythmic drugs in patients with new-onset atrial fibrillation. Am J Cardiol 2003;91:81-3
- Bardy GH, Lee KL, Mark DB, Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37